Evidence map›Paper›PMID 42507719›Full record

ArticlePLOS digital health2026

Validation is not enough: Longitudinal evidence of post-deployment fragility in clinical AI systems.

Georgy Kopanitsa

Abstract read
In one paragraph

Article in PLOS digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Georgy KopanitsaFederal State Budgetary Institution, V.A. Almazov National Medical Research Centre of the Ministry of Health of the Russian Federation, Saint-Petersburg, Russia.ORCID https://orcid.org/0000-0002-6231-8036

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pre-deployment validation is commonly used to establish the safety and effectiveness of clinical artificial intelligence systems, but acceptable validation performance does not guarantee stable behavior after deployment into routine clinical workflows. We conducted a longitudinal retrospective observational study of four clinically deployed AI systems operating across distinct clinical domains and workflows within a large healthcare organization. Using routinely collected clinical data, outcome labels, and operational telemetry, we compared validation-era performance with post-deployment behavior over extended observation periods. Analyses focused on temporal patterns of discrimination, calibration, data availability, latency, and workflow-related signals, with particular attention to label-dependent and label-independent monitoring. Across all systems, validation-era performance did not persist as a stable operational property after deployment. Calibration drift emerged consistently and often preceded detectable changes in discrimination. Workflow-associated changes in data availability and timing were more strongly and consistently associated with degradation than population-level indicators. Label-independent operational signals, including input missingness and data latency, provided early indication of emerging fragility, whereas outcome-based monitoring was delayed by label latency and documentation processes. These findings suggest that post-deployment fragility can be a structural property of clinical AI systems embedded in evolving workflows. Effective governance therefore requires lifecycle-oriented monitoring strategies that combine calibration reassessment with operational telemetry throughout deployment.

Identifiers

PMID42507719
PMCPMC13405297

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.